3-Methyladenine (3-MA)

Catalog No.S2767 Synonyms: NSC 66389

3-Methyladenine (3-MA) Chemical Structure

Molecular Weight(MW): 149.15

3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells; blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.

Size Price Stock Quantity  
In DMSO USD 64 In stock
USD 70 In stock
USD 370 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

4 Customer Reviews

  • MDC-labeled vacuoles were induced by AZD2014 and inhibited by autophagy inhibitor (3-MA). SMMC-7721 cells were treated with AZD2014 or rapamycin at concentrations of 100 and 600 nM, respectively, for 48 hours in the presence or absence of 3-MA, and then stained with MDC. Cells were immediately observed under a confocal microscope. Cells in the control group were treated with DMSO. bars, 20 μm.

    Am J Cancer Res, 2015, 5(1): 125-139. 3-Methyladenine (3-MA) purchased from Selleck.

    Cells were treated with DMSO, TDCIPP (100 μM) only, or pretreated with 3-MA before treatment with TDCIPP (100 μM). LC3 conversion and beclin-1 and p62 expression were assessed by western blotting at 24 h

    Food Chem Toxicol, 2017, 100:183-196. 3-Methyladenine (3-MA) purchased from Selleck.

  • PC-9/ER cells were treated with CX-4945 (5 mM) for 48 h in the presence or absence of 3-MA (2 mM) and Atg7 siRNA (100 nM). Cleavage of PARP-1 and caspase-3 was shown by Western blot analysis. CT: without CX-4945; CX: CX-4945; CX+G: CX-4945 + gefitinib; CX+E: CX-4945 + erlotinib.

    PLoS One, 2014, 9(12): e114000 . 3-Methyladenine (3-MA) purchased from Selleck.

    A: The survival ratio of AML12 cells was measured after treatment with rapamycin or 3-MA; B: Western blot was used to detect the expression of LC3 and P62 in AML12 cells treated with Rapamycin or 3-MA.

    World J Gastroenterol, 2016, 22(18): 4501-4514.. 3-Methyladenine (3-MA) purchased from Selleck.

Purity & Quality Control

Choose Selective PI3K Inhibitors

Biological Activity

Description 3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells; blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.
Targets
Vps34 [1]
(HeLa cells)
PI3Kγ [1]
(HeLa cells)
25 μM 60 μM
In vitro

The slight preference for Vps34 prevention by 3-Methyladenine probably arises from a hydrophobic ring specific to Vps34, which encircles the 3-methyl group of 3-Methyladenine. [1] 3-Methyladenine has been reported to cause cancer cell death under both normal and starvation conditions. 3-Methyladenine could also suppress cell migration and invasion independently of its ability to inhibit autophagy, implying that 3-Methyladenine possesses functions other than autophagy suppression. 3-Methyladenine elicits caspase-dependent cell death that is independent of autophagy inhibition. Treatment with 5 mM 3-Methyladenine reduces the percentage of glucose-starved HeLa cells displaying GFP-LC3 puncta to 23%. The levels of LC3-I are increasing and the levels of LC3-II are decreasing between 12 and 48 hours in cells that are treated with 3-Methyladenine. Conversion of LC3-I to LC3-II is suppressed by 3-Methyladenine. Treatment of HeLa cells with 3-Methyladenine at 2.5 mM or 5 mM for one day does not affect cell viability, whereas treatment with 10 mM 3-Methyladenine for one day causes a 25.0% decrease in cell viability. Treatment of cells with 2.5, 5 or 10 mM 3-Methyladenine for two days causes 11.5%, 38.0% and 79.4% decrease in viability, respectively. 3-Methyladenine decreases cell viability in a time- and dose-dependent manner. 3-Methyladenine significantly shortens the duration of nocodazole-induced-prometaphase arrest. [2] Suppression of autophagy by 3-Methyladenine inhibits SU11274-induced cell death. [3] Prolonged treatment with 3-Methyladenine (up to 9 hours) induces significant LC3 I to II conversion in wild type MEFs. Prolonged treatment with 3-Methyladenine, but not wortmannin, markedly increases GFP-LC3 punctuation/aggregation. 3-Methyladenine-induced LC3 conversion and free GFP liberation are ATG7-dependent. 3-Methyladenine treatment leads to evident increase of p62 protein level. 3-Methyladenine increases the p62 level even in Atg5−/− MEFs as well as in cells with DOX-mediated deletion of ATG5. 3-Methyladenine inhibits class I and class III PI3K in different temporal patterns. 3-Methyladenine-induced LC3 I to LC3 II conversion is dramatically compromised in Tsc2−/− cells compared with wild type cells.3-Methyladenine disrupts the anti-autophagic function of mTOR complex 1. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
95D NIHRcJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlqzN41O MXKybC=> M12xZWROW09? NUDmZXRkemWmdXPld{Boem:5dHigbY5pcWKrdH;yfUBm\m[nY4Sgc4YhSkSPQx?= MXmyOVcyPjV4MR?=
A549  MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWWzcW0> M{LIe|Jp M4jsOGROW09? MkjYdoVlfWOnczDndo94fGhiaX7obYJqfG:{eTDl[oZm[3Rib3[gRmROSw>? MknxNlU4OTZ3NkG=
95D NGLQWIRCeG:ydH;zbZMhSXO|YYm= MX[1cW0> NV;zSXJCOmh? MnzGSG1UVw>? MonYbY5pcWKrdIOgRmROSy2rbnT1Z4VlKGGyb4D0c5Rq[yClZXzsJIRm[XSq NGfEcZUzPTdzNkW2NS=>
A549  NIjldnJCeG:ydH;zbZMhSXO|YYm= NXe0T41yPW2P MWGybC=> NFPSbXlFVVOR MlTxbY5pcWKrdIOgRmROSy2rbnT1Z4VlKGGyb4D0c5Rq[yClZXzsJIRm[XSq NEXHcHgzPTdzNkW2NS=>
NBL-W-S  MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1K1[lFuVQ>? NF\BUm43cA>? Moj3[Y5p[W6lZYOgS2FPXC14MTD0c5hq[2m2eR?= MWOyOVMzOzJ{Mh?=
NBL-W-S  MXTBdI9xfG:|aYOgRZN{[Xl? M1fDSlFuVQ>? M1fpfVZp MWrpcoNz\WG|ZYOgZ4VtdCCjcH;weI9{cXNiaX7keYNm\CCkeTDHRW5VNTZz NYHLeW9{OjV|MkOyNlI>
A2780cp  M4LDZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvFNY1O MW[xbC=> M3ywPYlv[3KnYYPld{BkcXOybHH0bY4ucW6mdXPl[EBk\WyuIHTlZZRp MkXWNlU{OjJ4OUS=
A549  Mk[4SpVv[3Srb36gRZN{[Xl? MX21cW0> MYSybC=> MojYd5VxeHKnc4Pld{BUWENiaX7keYNm\CCjY3P1cZVt[XSrb36gc4YhVEN|LVnJ MWeyOVI5PTZ{OB?=
H157 NXviWYRPTnWwY4Tpc44hSXO|YYm= NGPYN2s2dU1? MkjhNog> MXvzeZBxemW|c3XzJHNRSyCrbnT1Z4VlKGGlY4XteYxifGmxbjDv[kBNSzNvSVm= Mk[zNlUzQDV4Mki=
MDR MXTBdI9xfG:|aYOgRZN{[Xl? MWGxNI1O MkfEOog> NFzwSIl{fHKnbnf0bIVveyC2aHWgdI94\XJib3[gZY51cWOjbnPldkBlenWpcx?= NVvmeoh6OjVyMUm3NFE>
HT-29  NGPsfppCeG:ydH;zbZMhSXO|YYm= NGnyXJcydU1? MX[0PIg> M16xPGROW09? NYTrN5Ro\W6qYX7j[ZMh[m:{dHX6c41q[i2rbnT1Z4VlKGOnbHygeoli[mmuaYT5JIxwe3N? M1jBXVI1QDR{MUW4
Microglia  Mm\tRZBweHSxc3nzJGF{e2G7 M{TrVFVuVQ>? NXzL[5FTOjSq MULk[YNz\WG|ZYOgbJlxd3irYT3pcoR2[2WmIHPlcIwh\GWjdHi= MmHoNlQ5OTh4MEG=
A2780cp NFHqNlhCeG:ydH;zbZMhSXO|YYm= M{LV[VIvPW2P M1PY[VFp NUTwXYNL\GSKMl:= NUnvSVJ{\W6qYX7j[ZMh[2m|cHzheIlvNWmwZIXj[YQh[2WubDDk[YF1cA>? NGC1ZZczPDhzN{m0Oi=>
HepG2 NUPNSpZlTnWwY4Tpc44hSXO|YYm= NFjie2c2dU1? M2fpe|Rp NVnaSpBHcW6lcnXhd4V{KEiOIILlcIVie2V? NWPa[W9UOjR5MUO1PFc>
A549 NWnUXI9HSXCxcITvd4l{KEG|c3H5 M1fpS|VuVQ>? NFraSY41QGh? MW\k[YNz\WG|ZYOgeIhmKHCncnPlcpRi\2Vib3[gZ4VtdCCmZXH0bEBidmRiZYjwdoV{e2mxbjDs[ZZmdHNib3[gZ4F{eGG|ZT2zMEBD\WOuaX6tNUBidmRiTFOzMWlK NXHwVVY6OjR5ME[zNFM>
U2OS NXHn[GJFSXCxcITvd4l{KEG|c3H5 NGrnO3cyOG2P NI\vXm0zPGh? NYHGVXpbcW62ZX7zbYZq\XNidHjlJIdzd3e2aDDpcohq[mm2aX;uJI9nKHSqZTDVNm9UKGOnbHzzJIlv\HWlZXSgZpkhTG:6 NHjMfY4zPDZ|OUCxNy=>
Saos-2 M1H1PWFxd3C2b4Ppd{BCe3OjeR?= NF;WWmcyOG2P M1z3UlI1cA>? NGS1bWNqdnSnboPp[olmeyC2aHWg[5Jwf3SqIHnubIljcXSrb36gc4YhfGinIGWyU3Mh[2WubIOgbY5lfWOnZDDifUBFd3h? NIDCWHgzPDZ|OUCxNy=>
A549 M2PoemFxd3C2b4Ppd{BCe3OjeR?= M3jPdFExdU1? M3rsWFQ5cA>? M33zeoFk[2WuZYLheIV{KHSqZTDy[YR2[3Srb36gc4Yh[2WubDD2bYFjcWyrdImgbY5lfWOnZDDifUBRXFh? M4PyWFI1PjJ4N{Ky
HCT116  MlvaRZBweHSxc3nzJGF{e2G7 NX\yW4o{PW2P M3rxOFI1cA>? MUflcohidmOnczD0bIUh[XCxcITvd4l{KGmwZIXj[YQh[nliYYDp[4VvcW5? NXHXcnA3OjR4Mk[1NlI>
HGC-27 MWnGeY5kfGmxbjDBd5NigQ>? MXyxNI1O MluxNYg> M1\YRolvcGmkaYTzJJRp\SClZXzsJJZq[WKrbHn0fUBtd3O|IHL5JHJCTDByMTDvdkBOUy1{MkC2 MWOyOFQyPjN2OR?=
U2OS  NES4fHdHfW6ldHnvckBCe3OjeR?= MYGwMlUwOW2P M4XVfFQ5cA>? MonobY5lfWOnczDzZYxqdm:veXPpck1qdmS3Y3XkJINmdGxidnnhZoltcXS7IHzvd5M> NVLrTHh1OjR|NUizOFI>
MG-63 M3XU[WZ2dmO2aX;uJGF{e2G7 MoH5NE42NzGvTR?= M1rpO|Q5cA>? NVT2cmV7cW6mdXPld{B{[Wyrbn;tfYNqdi2rbnT1Z4VlKGOnbHygeoli[mmuaYT5JIxwe3N? MVGyOFM2QDN2Mh?=
MG-63 M4rVW2Fxd3C2b4Ppd{BCe3OjeR?= NV62UI5sOC53L{HtUS=> MX[zNog> NVLPfJQ5\W6qYX7j[ZMhe2GuaX7vcZlkcW5vaX7keYNm\CClZXzsJIFxd3C2b4Ppdy=> M4\QO|I1OzV6M{Sy
MG-63 M3;xbGFxd3C2b4Ppd{BCe3OjeR?= MoXvNVBuVQ>? MnvGNVJp NF;OfoZmdmijbnPld{BFWC2rbnT1Z4VlKGGyb4D0c5Nqew>? NFXjO5AzPDN3OEOwNS=>
NTUB1 M3H1OWFxd3C2b4Ppd{BCe3OjeR?= M4C0dlVuVQ>? M2\iR|EvPWh? NHHRe4hxd3SnboTpZZRmeyClZXzlZ495cWJvaX7keYNm\CCjcH;weI9{cXN? NV6zS|hWOjR|NEmxO|Y>
T24 Mn\2RZBweHSxc3nzJGF{e2G7 MlfQOY1O M{TkdVEvPWh? MX3wc5RmdnSrYYTld{Bk\WynY3;4bYIucW6mdXPl[EBieG:ydH;zbZM> MWWyOFM1QTF5Nh?=
SGC-7901  MlvlRZBweHSxc3nzJGF{e2G7 M1jEVFJuVQ>? MliyNYg> NIHBZ2tqdmO{ZXHz[ZMhS0FvNDDpcoR2[2WmIHHwc5B1d3Orcx?= M3nPcVI1OzJzM{Sw
SMMC-7721 M3:2b2Fxd3C2b4Ppd{BCe3OjeR?= MY[ycW0> NF;jT|AycA>? NHjZSGhqdmO{ZXHz[ZMhS0FvNDDpcoR2[2WmIHHwc5B1d3Orcx?= NHL4RnUzPDN{MUO0NC=>
ECSCs  Ml3DRZBweHSxc3nzJGF{e2G7 MonLNVBuVQ>? NIrie|A1cA>? NELqfoxl\WO{ZXHz[ZMhemGyYX35Z4lvNXS{ZXH0[YQh[XCxcITvd4l{ NHfKbpkzPDNzOUGwPS=>
MCF-7  MmS3SpVv[3Srb36gRZN{[Xl? NE\6fFgyOG2P NWH4WFNFOjSq MnznbY5pcWKrdIOgeIhmKGG3dH;wbIFogSCrbnT1Z4VlKGK7IHPo[Y1wfGincnHwfUBlenWpcx?= NVXTWZlLOjR|MUW1O|g>
UOK257 Ml74RZBweHSxc3nzJGF{e2G7 NF34PFM2dU1? NI\qZVU{cA>? MkTX[Y5p[W6lZYOgdIFkdGm2YYjlcE1u\WSrYYTl[EBieG:ydH;zbZPDqA>? NF7sfoQzPDNyNU[wOC=>
ACHN-5968 MWfBdI9xfG:|aYOgRZN{[Xl? NWK2To9QPW2P M13MW|Np NFTvXmVmdmijbnPld{Bx[WOuaYThfIVtNW2nZHnheIVlKGGyb4D0c5Nqe8Li M4jidVI1OzB3NkC0
Huh7 NULRNXM6SXCxcITvd4l{KEG|c3H5 NWfI[VlKOm2P Ml3FNVJp NHzndnRFVVOR Ml7sbY5pcWKrdIOgRXpFQDB3NT3pcoR2[2WmIHPlcIwh\GWjdHi= M2PIeFI1Ojl5M{Cw
Hep3B NUi4T297SXCxcITvd4l{KEG|c3H5 MkXsNo1O MVqxNog> M2SzWmROW09? NHXPcJFqdmirYnn0d{BCYkR6MEW1MYlv\HWlZXSgZ4VtdCCmZXH0bC=> NWqwdWFnOjR{OUezNFA>
RKO MmDwSpVv[3Srb36gRZN{[Xl? MlXUNo1O M2rVTlFp NGPmTnNFVVOR NGDlbYdmdmijbnPld{Bk\WyuIHTlZZRpKGK7IHflcIRidmGveXPpci=> MVqyOFI6OTd5Nx?=
HepG2 E47 NH3WeYpHfW6ldHnvckBCe3OjeR?= M1HMcFIvPW2P MmXaOFhp NES0V4FqdmO{ZXHz[ZMhfGinIITvfIlkcXS7IH;mJGFCNCCEU1:sJIFv\CCFQ3y0 NGTyWm8zPDJ5M{ezPC=>
LoVo  Mlf4RZBweHSxc3nzJGF{e2G7 MXq1cW0> MV[0PIg> M{DBdIVvcGGwY3XzJGRESS2rbnT1Z4VlKGGyb4D0c5Nqey5? NW\ZUpV1OjR{MEG4NVI>
WiDr NYPLc49oTnWwY4Tpc44hSXO|YYm= M4LocVExdU1? MUSxbC=> M1TkWIlvcGmkaYTzJHBESkxvaX7keYNm\CCOQ{OgTWkh\XiycnXzd4lwdg>? M{XncFI1OTlyNEi5
H1299  MkOySpVv[3Srb36gRZN{[Xl? M1XRVFExdU1? MXW0bC=> NXvH[W9lcW6lcnXhd4V{KGOrc4DsZZRqdi2rbnT1Z4VlKGOnbHyg[IVifGh? M33OOFI1OTd|MkC4
H460 MV7GeY5kfGmxbjDBd5NigQ>? Moe2NVBuVQ>? M2LqNlRp NYD2SIptcW6lcnXhd4V{KGOrc4DsZZRqdi2rbnT1Z4VlKGOnbHyg[IVifGh? M4jHV|I1OTd|MkC4
A549 M2fucmZ2dmO2aX;uJGF{e2G7 M1yyU|ExdU1? MojqOIg> NV3iW|U4cW6qaXLpeJMh[XW2b4DoZYd6KGmwZIXj[YQh[nliaYLyZYRq[XSrb36= MXyyOFE1Ojd|NR?=
Hep3B NF7YdphCeG:ydH;zbZMhSXO|YYm= MWK1cW0> Mn3yNlRp MWHheJRmdnWjdHXzJHRPTi4QsTDwdo91\WO2aX;uJIFo[Wmwc4Sgd4VzfW1ic4ThdpZifGmxbj3t[YRq[XSnZDDhdI9xfG:|aYO= NV:wUVJKOjRyNk[2PVM>
SMMC-7721 NHL2bm5CeG:ydH;zbZMhSXO|YYm= M2XVRlVuVQ>? MVWyOIg> MlTEZZR1\W63YYTld{BVVkZvzsGgdJJwfGWldHnvckBi\2GrboP0JJNmenWvIIP0ZZJ3[XSrb36tcYVlcWG2ZXSgZZBweHSxc3nz NFLQN24zPDB4Nk[5Ny=>
HO8910 M3fL[GFxd3C2b4Ppd{BCe3OjeR?= NV;xW5hkOTCvTR?= NXfRdFI3OTKq NETHdYNmdmijbnPld{BDOTlvaX7keYNm\CCjcH;weI9{cQ>? NWn6e|RIOjN7OEO2NVA>
MCF7 NXjqZWprTnWwY4Tpc44hSXO|YYm= M{O2bFVuVQ>? MoO0NlRp Mn;ibY5kemWjc3XzJGN2VyCrbnT1Z4VlKGOnbHyg[IVifGh? M4\rdlI{QTZ{NkK5
HONE-1  M2LJb2Z2dmO2aX;uJGF{e2G7 M2LSOlVuVQ>? MlW1NYg> Mk\udoVxemW|c3XzJFZzNW2nZHnheIVlKFKRUzDwdo9lfWO2aX;u NW[yNnE4OjN6OUKzOVg>
HeLa M1frSWZ2dmO2aX;uJGF{e2G7 M33vXVExdU1? MkPRNog> NWPVT4FYe3WycILld5NmeyCOQ{OgTWkh\XiycnXzd4l{d25? M17nRlI{QDZ2N{O4
HepG2 MUXGeY5kfGmxbjDBd5NigQ>? M{n5flExdU1? NHrRPXczPGh? NGnq[5ZqdmirYnn0d{B{cVSLR1HSMUBidmRiSFLTV{1qdmS3Y3XkJIF2fG:yaHHnfS=> M3fVd|I{QDF5MESw
SH-SY5Y M1izTmZ2dmO2aX;uJGF{e2G7 MWexcW0> NXLpbHprOjSq NH3XbWFqdmirYnn0d{B1cGViYYX0c5Bp[We7IHnu[JVk\WRiYomgWG9EWA>? NUTFZ4d7OjN5NEOxOFg>
SH-SY5Y NFnrSpVCeG:ydH;zbZMhSXO|YYm= MVW1cW0> MXixbC=> NH7m[W1i[m:uaYPo[ZMh[2WuYYP0do9tKG6ndYLvdJJwfGWldHn2[UBm\m[nY4S= NGDBN3czOzZzOUO5OS=>
PC12  MkHySpVv[3Srb36gRZN{[Xl? MWixNI1O M4T2elI1cA>? NF7UTIl4[XSnch?= NXm0VWJHyqCrbnjpZol1eyClaIntc5RzgXC|aX6tcIls\SCycn;0[YF{d22jbDDhZ5Rqfmm2eT6= M2XmVlI{PjB|OUe5
OV2008 M1nDWmFxd3C2b4Ppd{BCe3OjeR?= MXS1cW0> NECwb5QzPGh? MmKxZ49vfmW{dIOgSnR[PzJyIIfpeIghS0SGUDDpcpRwKGGwIHHk[Il1cX[nIHXm[oVkfCC2b4fhdoR{KGurbHzpcochd3[jcnnhckBk[W6lZYKgZ4VtdHN? MUSyN|U6OjJ6MR?=
A2780 MljhRZBweHSxc3nzJGF{e2G7 MlrpOY1O MXmyOIg> M1vwRYNwdn[ncoTzJGZVYTd{MDD3bZRpKEOGRGCgbY51dyCjbjDh[IRqfGm4ZTDl[oZm[3RidH;3ZZJleyCtaXzsbY5oKG:4YYLpZY4h[2GwY3XyJINmdGy| NV3GVWs2OjN3OUKyPFE>
Saos-2  MXPBdI9xfG:|aYOgRZN{[Xl? NGLHc2sydU1? MXK5Oog> MXLpcoNz\WG|ZYOgZ4VtdCCmZXH0bEBqdmS3Y3XkJIJ6KFCFWB?= NULmd5BpOjN3NkOxO|E>
1321N1 M1XiXWN6fG:2b4jpZ4l1gSCDc4PhfS=> Ml7UOY1O MYmyOIg> MnnwdJJwfGWldIOgZ4VtdCCjZ3HpcpN1KFCFTj3pcoR2[2WmIITvfIlkcXS7 MXmyN|UzPTJ4NR?=
SH-SY5Y MlziR5l1d3SxeHnjbZR6KEG|c3H5 MoG5OY1O MUSyOIg> M{ntc4lv[3KnYYPld{BRS05idH;4bYNqfHl? M1G5XFI{PTJ3Mk[1
HT-29  NIr4XYRHfW6ldHnvckBCe3OjeR?= Mn;rNY1O NWTW[I5rPDhxOU\o NI\aSZFqdmirYnn0d{BCVVCNIHnu[JVk\XNiYYX0c5Bp[WerYzDj[YxtKGSnYYTo NH3YOGUzOzVyOEK3Ni=>
OR6 MlvESpVv[3Srb36gRZN{[Xl? MUexNI1O NYDOZXRJPzKq NUHoWJlie3WycILld5NmeyCKQ2[gdoVxdGmlYYTpc44h[W6mIH\vdo1ifGmxbjDv[kBifXSxcHjh[49{d22ncx?= MmGxNlM{QTV6N{W=
Hela  MmLtSpVv[3Srb36gRZN{[Xl? M3\wdlVuVQ>? NXixdmE4OjSq NYW1NW51cW6qaXLpeJMhe3Sjco\heIlwdi2rbnT1Z4VlKGG3dH;wbIFogQ>? M3qwblI{Ozl3Nke5
MCF-7  NX\nTY9lTnWwY4Tpc44hSXO|YYm= Mo\aOY1O M{G0WFI1cA>? MoXtbY5pcWKrdIOgd5Rien[jdHnvck1qdmS3Y3XkJIF2fG:yaHHnfS=> Mn;HNlM{QTV4N{m=
HUVECs MnzaSpVv[3Srb36gRZN{[Xl? MmPFN41O M3\V[lI1cA>? NYPNTW9j[myxY3vzJJRp\SCycn;0[YN1cX[nIHXm[oVkfCCxZjDy[ZN3\XKjdILvcEBjgSCrbnjpZol1cW6pIHH1eI9xcGGpeR?= NVT1emxVOjN|NUi5Nlg>
T24 M1Tx[mZ2dmO2aX;uJGF{e2G7 NIHFUWIyOG2P Mn71NYg> NEjuOXdz\WS3Y3XzJJRp\SClbHXheoFo\SCxZjDMR|Mh[W[2ZYKgZoFq[2GuaX6geJJm[XSvZX70 MonVNlM{PTRyOEC=
U251MG  NVfKZ5MzTnWwY4Tpc44hSXO|YYm= MmL6N41O M{f6d|Fp MYHzeZBxemW|c3XzJGxEOy2LSTDwdo91\WmwIHX4dJJme3Orb36= NFPzXFUzOzN|OE[xPC=>
GTL-16  NWTM[lNySXCxcITvd4l{KEG|c3H5 MlfEOY1O NFXaSlczPGh? M2nO[5Jm\HWlZYOgZ4VtdCC4aXHibYxqfHliYYOgZ49ueGG{ZXSgeI8h[2WubIOgeJJm[XSnZDD3bZRpKE2HVDDpcohq[mm2b4Lz M1TuVlI{OzF|NEmw
T-47D MUnGeY5kfGmxbjDBd5NigQ>? M{nRPVExdU1? M1rlWVJp NIn3OW9qdmirYnn0d{BifXSxcHjh[5kheHKxY3Xzd{BidmRiaX7jdoVie2W|IILhdIFugWOrbjDpcoR2[2WmIHHwc5B1d3Orcx?= NUnSbnl[OjN|MECwNlY>
PaCa44 M4D2PGFxd3C2b4Ppd{BCe3OjeR?= NFyySIgzNjWvTR?= MVqxbC=> MX3y[YR2[2W|wrDn[Y5qeGmwLX3l[IlifGWmIHHwc5B1d3Orcx?= MkDNNlMyOjRzMUK=
MDA-MB231 MoKySpVv[3Srb36gRZN{[Xl? MX:1cW0> Mmf6NYg> NF3PbWNqdmO{ZXHz[ZMhemW|dnXyZZRzd2xvbXXkbYF1\WRiY3HzdIF{\SCjY4TpeoF1cW:wIHHu[EBk\WyuIHTlZZRp NUnQPW5HOjNyOEi4OVA>
HeLa MXLBdI9xfG:|aYOgRZN{[Xl? M3f1TlExdU1? M1vUUlJp M1m2N4Rm[3KnYYPld{Bk\WyuII\pZYJqdGm2eTDjc{11emWjdH3lcpQhf2m2aDDQSWk> MmC1NlMxODBzM{W=
SK-HEP-1 NUXQZZlHSXCxcITvd4l{KEG|c3H5 MlrNNVBuVQ>? NH6xWGUycA>? MVTwdo91\WO2czDh[4FqdnO2IHH1eI9xcGGpeTDhcoQhcW6mdXPld{BieG:ydH;zbZMhcW5iYoXmZYxqdi22cnXheIVlKGOnbHzz MXyyNlg2QDZ2OR?=
HepG2 MWLBdI9xfG:|aYOgRZN{[Xl? MV2zcW0> NInVPJk2cA>? MWfy[YR2[2W|IHPlcIwh[XCxcITvd4l{KGmwZIXj[YQh[nliUVTz Mmn3NlI5OzZ3OUW=
MCF-7  M2nNdGZ2dmO2aX;uJGF{e2G7 MYSycW0> MYiyOIg> MoD0bY5pcWKrdIOgZZV1d3CqYXf5JIlv\HWlZXSgZpkhXE4EoB?= NH3wT3gzPDl5ME[3Oi=>
MDA-MB-231 MWHGeY5kfGmxbjDBd5NigQ>? MmG1No1O NGP3SnUzPGh? MmDhbY5pcWKrdIOgZZV1d3CqYXf5JIlv\HWlZXSgZpkhXE4EoB?= M3XFd|I1QTdyNke2
MCF-7  MUPGeY5kfGmxbjDBd5NigQ>? M2[yblJuVQ>? MmPpOFhp NHHtZWdxem:vb4Tld{BVVS2rbnT1Z4VlKGOnbHyg[IVifGh? NYTRXI9zOjR7N{C2O|Y>
MDA-MB-231 M3nFSGZ2dmO2aX;uJGF{e2G7 NHjvR3AzdU1? MmHMOFhp M{LINJBzd22xdHXzJHRONWmwZIXj[YQh[2WubDDk[YF1cA>? NEDSeJczPDl5ME[3Oi=>
PANC-1  M{T5Z2Fxd3C2b4Ppd{BCe3OjeR?= MV6xcW0> M2LmflQ5cA>? NUHXVpVMTE2VTx?= Mo\Y[Y5p[W6lZYOgZo9zfGW8b33pZk1qdmS3Y3XkJINmdGxidnnhZoltcXS7IHzvd5M> M2\EVVI1QDR{MUW4
MDA-MB 231 NX33TVZPSXCxcITvd4l{KEG|c3H5 NEHofI42dU1? MYSwMlVp NVG3PGVsdW:mdXzheIV{KFSxY3;tbY7DtsLiaX7keYNm\CCjcH;weI9{cXN? MnrhNlQ5OzB5OEG=
Microglia  M2S1UWFxd3C2b4Ppd{BCe3OjeR?= MnSxOY1O Mn\WNlRp Mofw[IVkemWjc3XzJIh6eG:6aXGtbY5lfWOnZDDj[YxtKGSnYYTo NHPafpYzPDhzOE[wNS=>
A2780cp M3jDRmFxd3C2b4Ppd{BCe3OjeR?= MlTpNk42dU1? NXvCO4RxOWh? MoPQ[IRJOk9? NUP3T3oy\W6qYX7j[ZMh[2m|cHzheIlvNWmwZIXj[YQh[2WubDDk[YF1cA>? NV;RTFZROjR6MUe5OFY>
HepG2 NGrUdWdHfW6ldHnvckBCe3OjeR?= MmPxOY1O MnXrOIg> NF:3XYRqdmO{ZXHz[ZMh[2WubIXsZZIhdGW4ZXzzJI9nKEiOwrC= MV6yOFcyOzV6Nx?=
U2OS NXL5TXQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEe2fogyOG2P NVLEcldFOjSq MVLpcpRmdnOrZnnld{B1cGViZ4Lve5RpKGmwaHnibZRqd25iaX7keYNm\CCkeTDEc5g> NH;PRVkzPDZ|OUCxNy=>
HCT116 MVLBdI9xfG:|aYOgRZN{[Xl? NXHRbWxTPW2P M3yyPFI1cA>? Mn;xSG1UVw>? M{XaNYVvcGGwY3XzJIFxcWenbnnuMYlv\HWlZXSgZ4VtdCCmZXH0bC=> NILCRXAzPDZ{NkWyNi=>
MCF-7  MWHBdI9xfG:|aYOgRZN{[Xl? MY[wMlFuVQ>? MUS2bC=> NWjIZYF1\W6qYX7j[ZMhe2m{dHnuc4wucW6mdXPl[EBieG:ydH;zbZM> M2nwdFIzPzVzOUi5
PC-3  NYjnNYhZSXCxcITvd4l{KEG|c3H5 MXKycW0> Mof6Nog> NH70THZqdmO{ZXHz[ZMhV1KLLXnu[JVk\WRiY3XscEBl\WG2aB?= MlPWNlI4PDV3OEC=
U251  NXvSS25HSXCxcITvd4l{KEG|c3H5 NXvENIRGPW2P Mn;HNlRp MlvubY5kemWjc3XzJHMyNWmwZIXj[YQh[2WubDDk[YF1cA>? NFK4[YwzOjV5OUe4PC=>
HeLa  NFjlXWZCeG:ydH;zbZMhSXO|YYm= M3S3fVVuVQ>? NULZUld7OjSq MYXpcoR2[2W|IHPhd5Bie2VvZHXw[Y5l\W62IHPlcIwh\GWjdHi= MnHsNlI2PDVzMki=
A549 M{TweGZ2dmO2aX;uJGF{e2G7 NE[3TG0xNjGvTR?= NEXQVWszPGh? NGOzOYR{fXCycnXzd4V{KFOXMUGyO|QucW6mdXPl[EBk\WyuIHTlZZRp MmjONlI1PjZ7NkC=
pDCs NUi0S|VoTnWwY4Tpc44hSXO|YYm= NHHERVgyOG2P M{jGc|AvPWh? NX60eplLyqC{ZXT1Z4V{KHSqZTDpcoR2[3Srb36gc4YhUU[QLd8xJIJ6KHO|Ul7BOFA> MUOyNlM6PjV7OR?=
BGC-823 MYfGeY5kfGmxbjDBd5NigQ>? NYrCXpdjPW2P MWOybC=> MXPpcohq[mm2czD0bIUhemG2ZTDv[kBifXSxcHjh[4lkKGOnbHzz M3;VXFIzOzJ{MUWy
U937 NWP2d5huTnWwY4Tpc44hSXO|YYm= NET3engzdU1? NVrSRVF4OTKq MUnk[YNz\WG|ZYOgeIhmKGG3dH;wbIFogSC{YYTpc:Kh MVeyNlE2PTF3MB?=
Marc-145 M1HqfWZ2dmO2aX;uJGF{e2G7 MojDOY1O NYHRdVlDOTJxMkSvN|Zp NX\tOndnemWmdXPld{B1cGViUGLSV3YhfGm2ZYLzJIFv\CC2aHWgdJJwfGWrbjDlfJBz\XO|aX;u NI\iS4MzOjFzOUmwNC=>
HBx  MWDBdI9xfG:|aYOgRZN{[Xl? M4rKT|ExdU1? M3PDVFQ5cA>? NEixNFlFVVOR NHrLemxqdmO{ZXHz[ZMh[2WubDDk[YF1cA>? MnLiNlIxOjByN{i=
MCF-7 NH3UXIJHfW6ldHnvckBCe3OjeR?= MnPyNVBuVQ>? MoD5OFhp Mon1Zoxw[2u|IHH1eI9xcGGpeTDpcoR2[2WmIHL5JIJwenSnen;tbYI> M2rUOVIyQTNzOUO3
RMPI8226  NIfzZXBHfW6ldHnvckBCe3OjeR?= Mn7iOY1O NHLXTooycA>? NGm4Z5R{fXCycnXzd4V{KHSqZTDs[ZZmdCCxZjDheZRweGijZ4mgeY5l\XJiboX0dolmdnRiZHXwcIV1cW:w MUGyNVkyPTZ{MB?=
PC12/TetOn NGPNXYFHfW6ldHnvckBCe3OjeR?= M{PNVFAvOS9zbV2= NH36XFAyQGh? NGq1[GJt\WGmczD0c{DPuS2|eX6oW3QqKGGlY4XteYxifGmxbjygeI95cWOrdImsJIFv\CCxbHnnc41meiCob4LtZZRqd28EoB?= NU\vOW5jOjF7ME[2OVk>
HeLa  NXfVPINDS3m2b4TvfIlkcXS7IFHzd4F6 M4jUNFJuVQ>? MVSyOIg> NWrv[pNbcW6qaXLpeIV{KHSqZTDjfZRwfG:6aXPpeJkhd2Zic3nsbYJqdmmwIITvJGhmVGFiY3XscJMv Mm\YNlE5PzV|OEW=
Jurkat M{jCV2Z2dmO2aX;uJGF{e2G7 MUmxNI1O MoW0NYg> M1HpeoRm[3KnYYPld{B1cGViZYjwdoV{e2mxbjDv[kBNSzNvSVmgZY5lKHSqZTDmc5Ju[XSrb36gc4Yh[XW2b4DoZYdwe2:vZYO= NVnCVHE1OjF6NkSwN|c>
K562 MY\GeY5kfGmxbjDBd5NigQ>? MYmxNI1O MV:xbC=> NHe5V|dl\WO{ZXHz[ZMhfGinIHX4dJJme3Orb36gc4YhVEN|LVnJJIFv\CC2aHWg[o9zdWG2aX;uJI9nKGG3dH;wbIFod3OxbXXz MYOyNVg3PDB|Nx?=
Nara-H NFu1WIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zSelVuVQ>? MWW0PIg> Mlez[Y5p[W6lZYOgeIVue2m{b3zpcZV{dWWmaXH0[YQhe3WycILld5Nqd25ib3[gUoFz[S2KIHPlcIwheHKxbHnm[ZJifGmxbh?= M1rnRVIyQDB3MEOz
HUVECs MnPkSpVv[3Srb36gRZN{[Xl? NHewWJYyOG2P NIC3dlcxNjWq MWHk[YNz\WG|ZYOgeIhmKEGJRT3CV2FqdmS3Y3XkJIF2fG:yaHHnfUBt\X[n M1fwV|IyPDZ6NUmy
HepG2 MlvxRZBweHSxc3nzJGF{e2G7 NGLPZWMzdU1? MlX5NYg> Mnix[Y5p[W6lZYOgdoFlcWG2aX;uMYlv\HWlZXSgZ4VtdCCmZXH0bC=> NX\pe|NOOjF2NUO2PVE>

... Click to View More Cell Line Experimental Data

In vivo 3-Methyladenine blocks autophagy through its effect on class III phosphatidylinositol 3-kinase (PI3K). 3-Methyladenine treatment does not alter the degree of hemorrhage compared with the subarachnoid hemorrhage (SAH) group. 3-Methyladenine pretreatment significantly aggravates neurological symptoms when compared with the SAH + vehicle group. Autophagy is decreased when 3-Methyladenine treatment is applied. Conversely, cleaved caspase-3 is markedly up-regulated in the SAH + 3-Methyladenine group. In line with the up-regulation of cleaved caspase-3 expression, the number of TUNEL-positive cells in the right cortex is significantly increased in the SAH + 3-Methyladenine group compared with the SAH + vehicle group. [5]

Protocol

Kinase Assay:[4]
+ Expand

Protein degradation assay:

HeLa cells are radiolabeled for 24 hours with 0.05 mCi/mL l-[U- 14C]valine. At the end of the labeling period, cells are rinsed three times with PBS. Cells are incubated for the designated times in either full medium or EBSS with or without the presence of 10 mM 3-Methyladenine.
Cell Research:[2]
+ Expand
  • Cell lines: HeLa cell line
  • Concentrations: 1-10 mM
  • Incubation Time: 24, 48 or 72 hours
  • Method: Cell (such as HeLa cell) viability is determined by a trypan blue exclusion assay. Briefly, after treated with 3-Methyladenine, both adherent and floating cells are collected and suspended in phosphate buffered saline (PBS, pH 7.4) at a final density of 1-2 × 106/mL. An equal volume of 0.4% trypan blue solution (w/v, in PBS) is added to the cell suspension and mixed thoroughly. After incubation at room temperature for 3 min, cell counting is performed using a hemacytometer.
    (Only for Reference)
Animal Research:[5]
+ Expand
  • Animal Models: Adult male Sprague–Dawley rats weighing 300-350 g
  • Formulation: Saline
  • Dosages: 400 nM
  • Administration: Intracerebral ventricular
    (Only for Reference)

Solubility (25°C)

In vitro Water 10 mg/mL warmed (67.04 mM)
Ethanol 4 mg/mL (26.81 mM)
DMSO 3 mg/mL warmed (20.11 mM)
In vivo Add solvents individually and in order:
water
10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 149.15
Formula

C6H7N5

CAS No. 5142-23-4
Storage powder
Synonyms NSC 66389

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    I'm also wondering whether it can be dissolved in water,or maybe something like culture medium,normal saline solution to form 10mM solution

  • Answer:

    As the reference (http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal. pone.0035665), 3-MA, which was found to inhibit autophagy at concentrations ranging from 1 to 10 mM was directly dissolved into the culture medium at the indicated concentrations. And we tested the solubility of S2767, and found the solubility of 3-MA in DMEM is 31 mg/mL at about 40°C.

PI3K Signaling Pathway Map

PI3K Inhibitors with Unique Features

Related PI3K Products

Tags: buy 3-Methyladenine (3-MA) | 3-Methyladenine (3-MA) supplier | purchase 3-Methyladenine (3-MA) | 3-Methyladenine (3-MA) cost | 3-Methyladenine (3-MA) manufacturer | order 3-Methyladenine (3-MA) | 3-Methyladenine (3-MA) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID